Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04201704 · ClinicalTrials.gov registry record · NA

Effect of Giving Reduced Fluid in Children After Trauma

A NA study of Critical Illness and Wounds and Injuries, sponsored by Columbia University.

Recruiting
Registry status
NA
Development phase
250
Enrollment target
4
Study locations

NCT04201704 is a NA study of Critical Illness and Wounds and Injuries that is actively recruiting participants, run by Columbia University. The registered enrollment target is 250 participants, below the 3,136-participant average among 91 other Critical Illness trials with a reported enrollment target (92% lower). The trial reports 4 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04201704, a NA study of Critical Illness and Wounds and Injuries, is actively recruiting participants, sponsored by Columbia University.

RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
4
Study locations

Study Summary

This study is designed to help decide how much intravenous (IV) fluid should be given to pediatric trauma patients. No standard currently exists for managing fluids in critically ill pediatric trauma patients, and many fluid strategies are now in practice. For decades, trauma patients got high volumes of IV fluid. Recent studies in adults show that patients actually do better by giving less fluid. The investigators do not know if this is true in children and this study is designed to answer that question and provide guidelines for IV fluid management in children after trauma.

Interventions

  • OTHER Balanced crystalloid solution volume administration
  • OTHER Packed Erythrocytes Units, Blood Product Unit volume
  • OTHER Plasma volume
  • OTHER Platelets volume

Study Locations (4)

New York

  • John R. Oishei Children's Hospital of Buffalo - Buffalo
  • Columbia University Irving Medical Center NewYork-Presbyterian Morgan Stanley Children's Hospital - New York
  • University of Rochester, Golisano Children's Hospital - Rochester

Tennessee

  • Le Bonheur Children's Hospital - Memphis

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2018-08-27
Est. Completion 2026-09
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT04201704

The ClinicalTrials.gov registry entry for NCT04201704 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,136-participant average among 91 other Critical Illness trials with a reported enrollment target (92% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Critical Illness appearing as the primary indexed condition, and to 4 interventions - of which Balanced crystalloid solution volume administration is the first listed.

NCT04201704 reports 4 study locations spanning 2 distinct geographic areas - top geographies include New York, Tennessee.

Frequently Asked Questions

What is clinical trial NCT04201704 about?

NCT04201704 is a clinical study titled "Effect of Giving Reduced Fluid in Children After Trauma". This study is designed to help decide how much intravenous (IV) fluid should be given to pediatric trauma patients. No standard currently exists for managing fluids in critically ill pediatric trauma patients, and many fluid strategies are now in practice. For decades, trauma patients got high volum...

What is the current status of trial NCT04201704?

This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2018-08-27. Estimated completion is 2026-09.

What conditions does trial NCT04201704 study?

This clinical trial studies the following conditions: Critical Illness, Wounds and Injuries, Pediatrics, General Surgery, Fluid Therapy.

What interventions are being tested in trial NCT04201704?

The interventions under investigation include: Balanced crystalloid solution volume administration (OTHER), Packed Erythrocytes Units, Blood Product Unit volume (OTHER), Plasma volume (OTHER), Platelets volume (OTHER).

Who is sponsoring clinical trial NCT04201704?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04201704 being conducted?

This trial has 4 study locations across New York, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Critical Illness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.